A multi-institutional study to assess adherence to lung stereotactic body radiotherapy planning goals

被引:6
|
作者
Woerner, Andrew [1 ]
Roeske, John C. [1 ]
Harkenrider, Matthew M. [1 ]
Fan, John [2 ]
Aydogan, Bulent [3 ]
Koshy, Matthew [3 ]
Laureckas, Robert [4 ]
Vali, Faisal [4 ]
Campana, Maria [1 ]
Surucu, Murat [1 ]
机构
[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[2] Edward Canc Ctr, Naperville, IL 60540 USA
[3] Univ Illinois, Dept Radiat Oncol, Chicago, IL 60612 USA
[4] Advocate Christ Med Ctr, Oak Lawn, IL 60453 USA
关键词
stereotactic body radiotherapy; SBRT; SABR; lung cancer; conformality; THERAPY ONCOLOGY GROUP; RADIATION-THERAPY; RESECTION; OUTCOMES;
D O I
10.1118/1.4926551
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: A multi-institutional planning study was performed to evaluate the frequency that current guidelines established by Radiation Therapy Oncology Group (RTOG) protocols and other literature for lung stereotactic body radiotherapy (SBRT) treatments are followed. Methods: A total of 300 patients receiving lung SBRT treatments in four different institutions were retrospectively reviewed. The treatments were delivered using Linac based SBRT (160 patients) or image guided robotic radiosurgery (140). Most tumors were located peripherally (250/300). Median fractional doses and ranges were 18 Gy (8-20 Gy), 12 Gy (6-15 Gy), and 10 Gy (5-12 Gy) for three, four, and five fraction treatments, respectively. The following planning criteria derived from RTOG trials and the literature were used to evaluate the treatment plans: planning target volumes, PTVV100 >= 95% and PTVV95 >= 99%; conformality indices, CI100% < 1.2 and CI50% range of 2.9-5.9 dependent on PTV; total lung-ITV: V-20Gy < 10%, V-12.5Gy < 15%, and V-5Gy < 37%; contralateral lung V-5Gy < 26%; and maximum doses for spinal cord, esophagus, trachea/bronchus, and heart and great vessels. Populations were grouped by number of fractions, and dosimetric criteria satisfaction rates (CSRs) were reported. Results: Five fraction regimens were the most common lung SBRT fractionation (46%). The median PTV was 27.2 cm(3) (range: 3.8-419.5 cm(3)). For all plans: mean PTVV100 was 94.5% (+/- 5.6%, planning CSR: 69.8%), mean PTVV95 was 98.1% (+/- 4.1%, CSR: 69.5%), mean CI100% was 1.14 (+/- 0.21, CSR: 79.1%, and 16.5% within minor deviation), and mean CI50% was 5.63 (+/- 2.8, CSR: 33.0%, and 28.0% within minor deviation). When comparing plans based on location, peripherally located tumors displayed higher PTVV100 and PTVV95 CSR (71.5% and 71.9%, respectively) than centrally located tumors (61.2% and 57.1%, respectively). Overall, the planning criteria were met for all the critical structure such as lung, heart, spinal cord, esophagus, and trachea/bronchus for at least 85% of the patients. Conclusions: Among the various parameters that were used to evaluate the SBRT plans, the CI100% and CI50% were the most challenging criteria to meet. Although the CSRs of organs at risk were higher among all cases, their proximity to the PTV was a significant factor. (C) 2015 American Association of Physicists in Medicine.
引用
收藏
页码:4629 / 4635
页数:7
相关论文
共 50 条
  • [31] Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study
    Cem Onal
    Ozan Cem Guler
    Pervin Hurmuz
    Guler Yavas
    Burak Tilki
    Ezgi Oymak
    Cagdas Yavas
    Gokhan Ozyigit
    Strahlentherapie und Onkologie, 2022, 198 : 940 - 948
  • [32] Impact of Dosimetric Factors on Local Failure in Patients with Spine Metastasis after Stereotactic Body Radiotherapy: A Multi-Institutional Study
    LeCompte, M. C.
    Chen, X.
    Tseng, C. L.
    Campbell, M.
    Balagamwala, E. H.
    Hanan, J.
    Byun, D. J.
    Silverman, J. S.
    Foote, M. C.
    Gatt, N.
    Mahadevan, A.
    Grimm, J.
    Redmond, K. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E89 - E89
  • [33] Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
    Rusthoven, Kyle E.
    Kavanagh, Brian D.
    Burri, Stuart H.
    Chen, Changhu
    Cardenes, Higinia
    Chidel, Mark A.
    Pugh, Thomas J.
    Kane, Madeleine
    Gaspar, Laurie E.
    Schefter, Tracey E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1579 - 1584
  • [34] Application of holographic display in radiotherapy treatment planning II: a multi-institutional study
    Chu, James C. H.
    Gong, Xing
    Cai, Yang
    Kirk, Michael C.
    Zusag, Thomas W.
    Shott, Susan
    Rivard, Mark J.
    Melhus, Christopher S.
    Cardarelli, Gene A.
    Hurley, Amanda
    Hepel, Jaroslaw T.
    Napoli, Josh
    Stutsman, Sandy
    Abrams, Ross A.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2009, 10 (03): : 115 - 124
  • [35] Vertebral Fractures Following Stereotactic Body Radiotherapy for Spine Oligometastases: A Multi-institutional Analysis of Patient Outcomes
    Abbouchie, H.
    Chao, M.
    Tacey, M.
    Joon, D. L.
    Ho, H.
    Guerrieri, M.
    Ng, M.
    Foroudi, F.
    CLINICAL ONCOLOGY, 2020, 32 (07) : 433 - 441
  • [36] An International Multi-institutional Planning Study Evaluating Treatment Planning and Plan Acceptability Metrics for Spine Stereotactic Body Radiation Therapy (SBRT)
    Tanaka, H.
    Furuya, T.
    Nihei, K.
    Ruschin, M. E.
    Pinnaduwage, D.
    Ma, L.
    Sahgal, A.
    Karasawa, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S69 - S69
  • [37] An International Multi-institutional Planning Study Evaluating Treatment Planning and Plan Acceptability Metrics for Spine Stereotactic Body Radiation Therapy (SBRT)
    Tanaka, H.
    Furuya, T.
    Nihei, K.
    Ruschin, M. E.
    Pinnaduwage, D.
    Ma, L.
    Sahgal, A.
    Karasawa, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S700 - S701
  • [38] The Role of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic and Oligoprogressive Gynecologic Malignancies: A Multi-Institutional Pooled Analysis
    Donovan, E.
    Albuquerque, K. V.
    Mantz, C. A.
    Beriwal, S.
    Keller, A.
    Chen, H.
    Lo, S. S.
    Leung, E. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S137 - S138
  • [39] Japanese Multi-institutional Study of Stereotactic Body Radiation Therapy For Renal and Adrenal Tumors
    Katoh, N.
    Onishi, H.
    Matsushita, H.
    Nomiya, T.
    Nakata, K.
    Shirato, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S467 - S467
  • [40] Patterns of Dose Prescription and Recording in Stereotactic Body Radiation Therapy: A Multi-institutional Study
    Das, I. J.
    Andersen, A. D.
    Bayliss, A.
    Chen, Z.
    Dimofte, A.
    Huang, L.
    Ai, H.
    Langer, M. P.
    Lee, C.
    Popple, R. A.
    Rice, R.
    Schiff, P. B.
    Zhu, T. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S68 - S69